[HTML][HTML] Dendrimers in the context of nanomedicine

AP Dias, S da Silva Santos, JV da Silva… - International journal of …, 2020 - Elsevier
Dendrimers are globular structures, presenting an initiator core, repetitive layers starting
radially from the core and terminal groups on the surface, resembling tree architecture …

X‐linked adrenoleukodystrophy: pathology, pathophysiology, diagnostic testing, newborn screening and therapies

BR Turk, C Theda, A Fatemi… - International Journal of …, 2020 - Wiley Online Library
Adrenoleukodystrophy (ALD) is a rare X‐linked disease caused by a mutation of the
peroxisomal ABCD1 gene. This review summarizes our current understanding of the …

Dendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial

AM Gusdon, N Faraday, JS Aita, S Kumar… - Science translational …, 2022 - science.org
Hyperinflammation triggered by SARS-CoV-2 is a major cause of disease severity, with
activated macrophages implicated in this response. OP-101, a hydroxyl-polyamidoamine …

Antioxidative nanomaterials and biomedical applications

Y Liu, J Shi - Nano Today, 2019 - Elsevier
Highlights•This review article offers an in-depth overview of significant advances in the field
of antioxidative nanotechnology.•The pathology and molecular mechanisms of oxidative …

Nanoparticle-based targeting of microglia improves the neural regeneration enhancing effects of immunosuppression in the zebrafish retina

K Emmerich, DT White, SP Kambhampati… - Communications …, 2023 - nature.com
Retinal Müller glia function as injury-induced stem-like cells in zebrafish but not mammals.
However, insights gleaned from zebrafish have been applied to stimulate nascent …

[HTML][HTML] Dendrimer-2PMPA selectively blocks upregulated microglial GCPII activity and improves cognition in a mouse model of multiple sclerosis

KR Hollinger, A Sharma, C Tallon, L Lovell… - …, 2022 - ncbi.nlm.nih.gov
Cognitive impairment is a common aspect of multiple sclerosis (MS) for which there are no
treatments. Reduced brain N-acetylaspartylglutamate (NAAG) levels are linked to impaired …

N-acetylcysteine pharmacology and applications in rare diseases—Repurposing an old antioxidant

SA Sahasrabudhe, MR Terluk, RV Kartha - Antioxidants, 2023 - mdpi.com
N-acetylcysteine (NAC), a precursor of cysteine and, thereby, glutathione (GSH), acts as an
antioxidant through a variety of mechanisms, including oxidant scavenging, GSH …

Biomarker identification, safety, and efficacy of high-dose antioxidants for adrenomyeloneuropathy: a phase II pilot study

C Casasnovas, M Ruiz, A Schlüter, A Naudí… - …, 2019 - Springer
Abstract X-Adrenoleukodystrophy (X-ALD) and its adult-onset, most prevalent variant
adrenomyeloneuropathy (AMN) are caused by mutations in the peroxisomal transporter of …

Targeted Brain Delivery of Dendrimer-4-Phenylbutyrate Ameliorates Neurological Deficits in a Long-Term ABCD1-Deficient Mouse Model of X-Linked …

CL Nemeth, Ö Gӧk, SN Tomlinson, A Sharma… - …, 2023 - Springer
X-linked adrenoleukodystrophy (ALD) is a genetic disorder that presents neurologically as
either a rapid and fatal cerebral demyelinating disease in childhood (childhood cerebral …

Targeted Microglial Attenuation through Dendrimer–Drug Conjugates Improves Glaucoma Neuroprotection

I Pitha, S Kambhampati, A Sharma, R Sharma… - …, 2023 - ACS Publications
Retinal microglial/macrophage activation and optic nerve (ON) microglial/macrophage
activation are glaucoma biomarkers and potential therapeutic targets for this blinding …